Home | Bio | Vitae | Publications | About | Contact | Industry Links | Directions | Interests
Richard L. Mitchell, Ph.D.

bleeding_hearts_2005-hr.jpg

Broadly experienced in the pharma and biotech industry.
  • Laboratory and business leadership
  • Strategic alliances
  • Contract management
  • Business development
  • Sales
  • IT system & website designs

Please review my resume/vitae, and learn more about the view of those that have worked with me (see "About" section of this website).  I welcome the opportunity to discuss how I might help your company grow!

 

Thursday, October 27, 2005

Science blog to appear on these pages...
I will begin posting links to interesting scientific articles from this location in my website. 
 
There are some great new technologies for discovering and characterizing drugs, and this blog will focus on some of the recent scientific advances that will help bring new drugs to market. 
 
One recently developed technology is referred to as "cellular dielectric spectroscopy", and has been brought to market recently by MDS Sciex.  The technology is an outgrowth of work originally done by Signature Biosciences, and is a practical application of technologies that had their inception at Stanford University (where the original work was known as "microwave coupling sprectroscopy".
 
Another interesting technology, also from Stanford, comes from the laboratory of Dr. Garry Nolan.  His group has pushed the limits of polychromatic flow cytometry.  Omar Perez, in Garry's group, has applied polychromatic flow cytometry to study signal transduction, at the cellular level.  By coupling the power of flow cytometry to look at thousands of cells per second individually, Omar Perez and others in Garry's group can 1) identify specific cell types and 2) quantify the activation state of specific cellular signaling pathways.  This is a powerful capability with many applications in drug discovery and development (more on this in the days to come!).  Combined with Bayesian analysis, they are able to use this information to identify new, previously unknown, members of signaling pathways (ie. they can find a "black box" that controls or influences the behavior of members of the signaling pathway, without even having a means to observe the "black box" directly.  This is a powerful approach to identify new targets for drug discovery. 
 
I will attempt to illuminate some of these interesting new technologies on this blog in the days to come...
 
Richard Mitchell
5:28 am pdt

2005.10.01

Link to web log's RSS file

Richard Mitchell, Ph.D.
Drug Discovery & Development Consulting, Technology Assessment
Proven Results-Oriented Visionary Leadership
15920 177th Ave NE
Woodinville, WA 98072
USA

Phone: (425) 402-6341
Cell:     (425) 922-1393
Fax:     (425) 922-1393

mitchellscience@verizon.net

enchantedforest.jpg

Picking the right consultant can be challenging. You want an individual that is experienced, and creative in ways that will meet your specific challenge, and broad enough to communicate with all of your staff.  I have the vision and creativity you need to drive your business forward, and the breadth to work well with all of your scientific and business staff.

Please visit the Bio and Vitae pages for specific information on my background.  I've received many accolades over the years, from colleagues, business associates, and customers.  A small number of these comments are posted on the "About" page on this website.

Please get in touch for more information and to join my mailing list. I look forward to working with you.

Richard L. Mitchell, Ph.D.
Discovery & Development Consulting, Technology Assessment
15920 177th Ave. NE
Woodinville, WA 98072 USA
+425.402.6341
+425.922.1393 (cell)
mitchellscience@verizon.net (principal e-mail)
richard@touchinglightphotography.com (alt. e-mail)